Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 259

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Treatment Outcomes of Resected Esophageal Cancer

Open access
Hofstetter, Wayne, Swisher, Stephen G., Correa, Arlene M., Hess, Kenneth, Putnam, Joe B., Ajani, Jaffer A., Dolormente, Marcelo, Francisco, Rhodette, Komaki, Ritsuko R., Lara, Axbal, Martin, Faye, Rice, David C., Sarabia, Arcenio J., Smythe, W. Roy, Vaporciyan, Ara A., Walsh, Garrett L., Roth, Jack A.·2002·Annals of Surgery

Abstract

OBJECTIVE: To assess the evolution of treatment and outcome for resected esophageal cancer at a single institution. SUMMARY BACKGROUND DATA: Strategies for optimizing the treatment of resected esophageal cancer continue to evolve over time. The outcomes of these evolving treatments in the context of improved diagnostic staging and changing epidemiology have not been carefully analyzed in a single institution. METHODS: One thousand ninety-seven consecutive patients with primary esophageal cancer underwent surgery during the period 1970 to 2001. Nine hundred ninety-four patients underwent curative esophagectomy and were analyzed for changing demographics. Eight hundred seventy-nine patients who did not have systemic metastases and survived the perioperative period were assessed by multivariate analysis for factors associated with long-term survival. RESULTS: During the study period the overall median survival increased from 17 to 34 months, and combined hospital and 30-day mortality decreased from 12% to 6%. The R0 resection rate increased from 78 to 94%, and adenocarcinoma replaced squamous cell carcinoma as the predominant histology (83% vs. 17%). No change in survival with time was noted for patients treated with surgery alone having the same postoperative pathologic stage (pTNM). An increased proportion of patients had preoperative chemoradiation in the last 4 years of the study (59% vs. 2%). Preoperative chemoradiation was associated with a longer survival and increased likelihood of achieving a complete resection. Multivariate analysis showed that long-term survival was associated with a complete resection and the preoperative staging strategy used, while the use of preoperative chemoradiation was the most significant factor associated with ability to achieve an R0 esophageal resection. CONCLUSIONS: This study shows favorable trends in the survival of patients with resected esophageal cancer over time. The increased use of preoperative chemoradiation, better preoperative staging, and other time-dependent factors may have contributed to the observed increase in survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000658-200209000-00014

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 259

Metadata

Authors
Hofstetter, W., Swisher, S. G., Correa, A. M., Hess, K., Putnam, J. B., Ajani, J. A., Dolormente, M., Francisco, R., Komaki, R. R., Lara, A., Martin, F., Rice, D. C., Sarabia, A. J., Smythe, W. R., Vaporciyan, A. A., Walsh, G. L., & Roth, J. A.
Venue
Annals of Surgery
Published
2002-09
Volume
236
Issue
3
Pages
376-385
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2315843358
Cited by
259
References
17
FWCI
13.31
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment Outcomes of Resected Esophageal Cancer. https://app.cochat.ai/papers/10.1097/00000658-200209000-00014
The paper
Hofstetter, W., Swisher, S. G., Correa, A. M., Hess, K., Putnam, J. B., Ajani, J. A., Dolormente, M., Francisco, R., Komaki, R. R., Lara, A., Martin, F., Rice, D. C., Sarabia, A. J., Smythe, W. R., Vaporciyan, A. A., Walsh, G. L., & Roth, J. A. (2002). Treatment Outcomes of Resected Esophageal Cancer. Annals of Surgery. https://doi.org/10.1097/00000658-200209000-00014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.